These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 8425767)
1. Inhibition of growth-factor-activated proliferation by anti-estrogens and effects on early gene expression of MCF-7 cells. Wosikowski K; Küng W; Hasmann M; Löser R; Eppenberger U Int J Cancer; 1993 Jan; 53(2):290-7. PubMed ID: 8425767 [TBL] [Abstract][Full Text] [Related]
2. Estradiol increases and anti-estrogens antagonize the growth factor-induced activator protein-1 activity in MCF7 breast cancer cells without affecting c-fos and c-jun synthesis. Philips A; Chalbos D; Rochefort H J Biol Chem; 1993 Jul; 268(19):14103-8. PubMed ID: 8314777 [TBL] [Abstract][Full Text] [Related]
3. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1. Lykkesfeldt AE; Madsen MW; Briand P Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264 [TBL] [Abstract][Full Text] [Related]
4. C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells. Venditti M; Iwasiow B; Orr FW; Shiu RP Int J Cancer; 2002 May; 99(1):35-42. PubMed ID: 11948489 [TBL] [Abstract][Full Text] [Related]
5. c-fos, c-jun and c-myc expressions are not growth rate limiting for the human MCF-7 breast cancer cells. Wosikowski K; Eppenberger U; Küng W; Nagamine Y; Mueller H Biochem Biophys Res Commun; 1992 Nov; 188(3):1067-76. PubMed ID: 1445344 [TBL] [Abstract][Full Text] [Related]
6. Stimulation of DNA synthesis and c-fos mRNA expression in primary rat hepatocytes by estrogens. Lee CH; Edwards AM Carcinogenesis; 2001 Sep; 22(9):1473-81. PubMed ID: 11532870 [TBL] [Abstract][Full Text] [Related]
7. Effect of growth factors on estrogen receptor mediated gene expression. Hafner F; Holler E; von Angerer E J Steroid Biochem Mol Biol; 1996 Jul; 58(4):385-93. PubMed ID: 8903422 [TBL] [Abstract][Full Text] [Related]
8. Anti-proliferative and anti-estrogenic effects of ICI 164,384 and ICI 182,780 in 4-OH-tamoxifen-resistant human breast-cancer cells. Coopman P; Garcia M; Brünner N; Derocq D; Clarke R; Rochefort H Int J Cancer; 1994 Jan; 56(2):295-300. PubMed ID: 8314314 [TBL] [Abstract][Full Text] [Related]
9. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gründker C; Völker P; Schulz KD; Emons G Gynecol Oncol; 2000 Aug; 78(2):194-202. PubMed ID: 10926802 [TBL] [Abstract][Full Text] [Related]
10. Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells. Wakeling AE; Newboult E; Peters SW J Mol Endocrinol; 1989 May; 2(3):225-34. PubMed ID: 2665780 [TBL] [Abstract][Full Text] [Related]
11. Effects of tamoxifen and retinoic acid on cell growth and c-myc gene expression in human breast and cervical cancer cells. Tsai LC; Hung MW; Yuan CC; Chao PL; Jiang SY; Chang GG; Chang TC Anticancer Res; 1997; 17(6D):4557-62. PubMed ID: 9494568 [TBL] [Abstract][Full Text] [Related]
12. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T-47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro. Simard J; Labrie C; Bélanger A; Gauthier S; Singh SM; Mérand Y; Labrie F Int J Cancer; 1997 Sep; 73(1):104-12. PubMed ID: 9334816 [TBL] [Abstract][Full Text] [Related]
13. Modulation by phenylacetate of early estrogen-mediated events in MCF-7 breast cancer cells. Liu J; Li J; Sidell N Cancer Chemother Pharmacol; 2007 Feb; 59(2):217-25. PubMed ID: 16738884 [TBL] [Abstract][Full Text] [Related]
14. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Pink JJ; Jordan VC Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307 [TBL] [Abstract][Full Text] [Related]
15. Regulation of estrogen receptor messenger ribonucleic acid and protein levels in human breast cancer cell lines by sex steroid hormones, their antagonists, and growth factors. Read LD; Greene GL; Katzenellenbogen BS Mol Endocrinol; 1989 Feb; 3(2):295-304. PubMed ID: 2785242 [TBL] [Abstract][Full Text] [Related]
16. Cyr61, a member of the CCN family, is required for MCF-7 cell proliferation: regulation by 17beta-estradiol and overexpression in human breast cancer. Sampath D; Winneker RC; Zhang Z Endocrinology; 2001 Jun; 142(6):2540-8. PubMed ID: 11356703 [TBL] [Abstract][Full Text] [Related]
17. Flaxseed alone or in combination with tamoxifen inhibits MCF-7 breast tumor growth in ovariectomized athymic mice with high circulating levels of estrogen. Chen J; Power KA; Mann J; Cheng A; Thompson LU Exp Biol Med (Maywood); 2007 Sep; 232(8):1071-80. PubMed ID: 17720953 [TBL] [Abstract][Full Text] [Related]
18. Synthetic antiestrogens modulate induction of pS2 and cathepsin-D messenger ribonucleic acid by growth factors and adenosine 3',5'-monophosphate in MCF7 cells. Chalbos D; Philips A; Galtier F; Rochefort H Endocrinology; 1993 Aug; 133(2):571-6. PubMed ID: 8344199 [TBL] [Abstract][Full Text] [Related]
19. Comparison between novel steroid-like and conventional nonsteroidal antioestrogens in inhibiting oestradiol- and IGF-I-induced proliferation of human breast cancer-derived cells. de Cupis A; Noonan D; Pirani P; Ferrera A; Clerico L; Favoni RE Br J Pharmacol; 1995 Nov; 116(5):2391-400. PubMed ID: 8581274 [TBL] [Abstract][Full Text] [Related]
20. C-myc overexpression, c-mil, c-myb expression in a breast tumor cell line. Effects of estrogen and antiestrogen. Collyn-d'Hooghe M; Vandewalle B; Hornez L; Lantoine D; Revillion F; Lefebvre J; Kerckaert JP Anticancer Res; 1991; 11(6):2175-9. PubMed ID: 1776859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]